Plasma Biomarker in Amblyopia Patients

Sex: All

Ages: 3 Years – 12 Years

Healthy volunteers: 1

Enrollment: 600

Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University

Summary

This prospective study aims to observe the predictive effect of peripheral blood plasma biomarker on the outcome of treatment in children with different types of amblyopia. We also investigated the mechanism of neuromodulation in the visual development of amblyopic children.

Eligibility Criteria

Inclusion Criteria:Diagnosed with amblyopia3-12 years of ageAble to tolerate amblyopia treatmentAgree to be involved in this study and agree to have a follow up visit every 3 months.Exclusion Criteria:Have previous treatment history beforeHave pathological ocular anomalies known to cause reduced visual acuityHave previous psychiatric, visual or neurological disordersHave eccentric fixation and/or abnormal retinal correspondenceHave attention disorder and learning disability that cannot comprehend psychophysical test instructions given and/or consent for themselves

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05705778). StuddyBuddy aggregates publicly available trial information.